Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015–2019)
International Journal of Chronic Obstructive Pulmonary Disease · 2025-06 · Volume 20 · 1851-1864
DOI: 10.2147/copd.s513573 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Chronic Obstructive Pulmonary Disease, 2025-06. Verfasst von Clementine Nordon und 8 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Evidence Strategy, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Bronchodilator Agents, Adrenal Cortex Hormones, Lung. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: AstraZeneca.
Themen: COPD
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Respiratory Evidence Strategy, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
- US Medical Evidence, Biopharmaceuticals, AstraZeneca, Wilmington, DE, USA.
- Global Medical, BioPharmaceuticals Medical, AstraZeneca, Gothenburg, Sweden.
- Value & Evidence Solutions, Optum Life Sciences, Eden Prairie, MN, USA.
- School of Medicine, Johns Hopkins Medicine, Baltimore, MA, USA.
ORCID-Profile: Hana Müllerová, Timothy L Barnes, Meredith C McCormack
Förderung
- AstraZeneca
Zitieren
APA
Nordon, C., Carstens, D., Fagerås, M., Müllerová, H., Veeranki, P. S., Alves, J. A., Germack, H. D., Barnes, T. L., & McCormack, M. C. (2025). Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015–2019). International Journal of Chronic Obstructive Pulmonary Disease, Volume 20, 1851-1864. https://doi.org/10.2147/copd.s513573
Vancouver
Nordon C, Carstens D, Fagerås M, Müllerová H, Veeranki PS, Alves JA, et al. Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015–2019). International Journal of Chronic Obstructive Pulmonary Disease. 2025;Volume 20:1851-1864. doi:10.2147/copd.s513573
BibTeX
@article{Nordon2025,
author = {Nordon, Clementine and Carstens, Donna and Fagerås, Malin and Müllerová, Hana and Veeranki, Phani S and Alves, João André and Germack, Hayley D and Barnes, Timothy L and McCormack, Meredith C},
title = {Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015–2019)},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2025},
volume = {Volume 20},
pages = {1851--1864},
doi = {10.2147/copd.s513573}
}
EUVIMED